Savient Pharma (SVNT) Tops Q3 EPS by 1c

November 3, 2011 7:03 AM EDT
Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) reported Q3 loss of ($0.39), $0.01 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $2.58 million versus the consensus estimate of $3.17 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings